Increase in pneumococcus macrolide resistance, USA

Emerging Infectious Diseases

Volumn 16, Issue 5, 2010, Pages 896-897

  Hicks, Lauri A ^a   Monnet, Dominique L ^b   Roberts, Rebecca M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CHILD HEALTH; DRUG USE; HUMAN; LETTER; NONHUMAN; OUTPATIENT; PNEUMOCOCCAL INFECTION; PRESCRIPTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 77951158983     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1605.091424     Document Type: Letter

References (5)

1. Jenkins SG, Farrell DJ. Increase in pneumococcus macrolide resistance, United States. Emerg Infect Dis. 2009;15:1260-4. DOI: 10.3201/eid1508.081187
2. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87.
3. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302:758-66. DOI: 10.1001/jama.2009.1163
4. Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA. 2001;286:1857-62. DOI: 10.1001/jama.286.15.1857
5. Dagan R, Barkai G, Givon-Lavi N, Sharf A, Vardy D, Cohen T, et al. Seasonality of antibiotic-resistant Streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis. 2008;197:1094-102. DOI: 10.1086/528995